Jung-Yun Lee

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer

Byungsoo Ahn, Damin Moon, Chung Lee et al. · Nature Communications · 2024 · 61 citations · Full text

Medicine, Gynecology, Oncology +17

Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial

Toon Van Gorp, Kathleen Moore, Gottfried E. Konecny et al. · The Lancet Oncology · 2025 · 28 citations

Medicine, Oncology, Pharmacotherapy +13

Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial

Marie Plante, Sven� Mahner, Alexandra Sebastianelli et al. · International Journal of Gynecological Cancer · 2024 · 15 citations · Full text

Medicine, Gynecology, Surgery +14

Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125

Amal Alsomairi, Samah Himayda, Ahmed Altelmesani et al. · Gynecologic Oncology · 2024 · 14 citations

Medicine, Oncology, Surgery +16